CBWTF - Auxly Cannabis Group Inc.
| Previous Close | 0.7000 |
| Open | 0.6851 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.6695 - 0.7115 |
| 52 Week Range | 0.4440 - 1.2600 |
| Volume | 577,788 |
| Avg. Volume | 1,088,526 |
| Market Cap | 405.443M |
| Beta (3Y Monthly) | 8.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0750 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire
Auxly Announces Receipt of Key Cannabis Oil Sales Liceneces for Dosecann and Kolab Project
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiaries, Dosecann Inc. (“Dosecann”) and Kolab Project Inc. (“Kolab”) have both been authorized by Health Canada to sell cannabis oil under the Cannabis Regulations. The issuance of these sales licences marks a significant milestone for Auxly in furthering its strategy to deliver branded derivative cannabis products to market when such products become legal later this year.
- GlobeNewswire
Auxly, Together with its Strategic Partner, Atlantic Cultivation, Enters into a Comprehensive Supply, Development and Retail Agreement with Newfoundland & Labrador
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company"), together with its strategic partner, Atlantic Cultivation (“Atlantic”), is thrilled to announce today that it has entered into a comprehensive supply, development and retail agreement with the Province of Newfoundland and Labrador. The agreement marks a significant milestone in the establishment of Auxly’s presence in Atlantic Canada. Under the terms of the agreement, Atlantic will be eligible to apply to operate five new retail locations in the province.
- Motley Fool
4 Cannabis Stocks Projected to Grow Sales by at Least 355% Next Year
These pot stocks should deliver supercharged revenue growth in 2020.
- Motley Fool
Wholesale Cannabis Prices Are Rising in Established U.S. States -- Here's Why
Following a long downturn in wholesale marijuana prices, Colorado, Oregon, and Washington are suddenly pulling a 180.
- GlobeNewswire
Auxly Enters Into a 300 Acre Hemp Cultivation and Purchase Agreement for the 2019 Cultivation Season
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that it has entered into a hemp cultivation and purchase agreement (the “Agreement”) pursuant to which the Company has agreed to act as the financial sponsor for the development of a hemp farming co-operative consisting of six individual hemp licence holders pursuant to the Cannabis Act (collectively, the “Hemp Farmers”) located in Prince Edward Island. To date, the Company has funded $4.5 million of the approximately $6 million it will advance and the Hemp Farmers have planted nearly 300 acres of hemp, which is expected to result in approximately 100,000 kilograms of hemp biomass.
- GlobeNewswire
Auxly Reports Q2 2019 Financial Results and Subsequent Financing Activities of Over $200 Million
VANCOUVER, British Columbia, Aug. 16, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the.
- GlobeNewswire
Auxly Announces Signing Of Term Sheet For $84 Million Credit Facilities Through Its Joint Venture Partner, Sunens Farms Inc.
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“Sunens”), has entered into a term sheet for a syndicated credit facility, with the Bank of Montreal (“BMO”) as Lead Underwriter and, subject to the satisfaction of certain customary closing conditions and the finalization of definitive loan documentation, expects to receive debt financing in the aggregate amount of approximately $84 million. The syndicated senior debt facility will be for $71.5 million (the “Credit Facility”) for a three-year term together with a BMO $12.5 million leasing facility (the “Leasing Facility”). Sunens is a fully automated, purpose-built greenhouse for cannabis cultivation currently under construction in Leamington, Ontario.
- GlobeNewswire
Auxly Announces CEO Succession
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its Board of Directors has named Hugo Alves, President, to succeed Chuck Rifici as CEO, effective August 27, 2019. Mr. Rifici will continue to serve as Chairman of Auxly’s Board of Directors.
- Motley Fool
2 Best Cannabis Stocks to Buy in August
Auxly Cannabis Group and Charlotte's Web Holdings are poised for serious growth.
- TipRanks
Will Imperial Brands Investment in Auxly Cannabis Group be Enough to Deliver the Goods?
A lot of shareholders and former shareholders have soured on Auxly Cannabis Group (CBWTF) because of low performance, a weak stable of companies, and questions about its ability to survive long enough to deliver on its streaming business model.The company recently received a reprieve from some of this concerns after it was announced the British-based tobacco firm Imperial Brands was investing C$123 million ($93.4 million) into Auxly.Terms of the dealThe C$123 million investment came by means of a convertible debenture. The conversion price was set at C$0.81 per share. At the time of the announcement it presented an 11 percent premium over the closing price of the prior trading session. Per terms of the deal Imperial Brands included an option to exercise the note at any time during the three-year term. If Imperial chooses not to convert, the debenture is required to be repaid in full.On the part of Imperial, that's a very safe bet. It's getting just under 20 percent of Auxly Cannabis for what is essentially kicking the tires, i.e., a trial run.Benefit to AuxlyEven though Auxly predictably got a quick boost to its share price when the cash infusion was announced, it hasn't been able to hold, and the share price has dropped back to trading between 60 cents and 70 cents. This, as mentioned earlier, is because of the negative sentiment associated from the company on past under performance and growing discontent from many retail shareholders in particular.That said, it has to be admitted that the C$123 million definitely changes the possibilities and flexibility of the company, as it should be able to complete construction on its wholly-owned farm construction, along with a joint venture it has been working on.In the near term, the additional capital will help it build out a portfolio of derivative products that will be allowed to be sold in Canada in the latter part of 2019.Of those, vapes are projected and expected to be one of the top-selling derivatives, which will strengthened by Auxly's access to Nerudia products, which competes in the vaping market. Vapes and other derivatives command higher prices, which will generate wider margins and earnings.Last, the distribution network of Imperial Brands extends to global markets, and that should provide Auxly with fast access to those markets. Imperial's experience in marketing to those disparate markets should allow Auxly to leverage it to accelerated growth.ConclusionIt can't be overstated how much Auxly Cannabis Group needed this type of deal. The company had been floundering and many questions have been raised by disgruntled shareholders and former investors as to the viability of the business model of the company, and its ability to execute it profitably.With the company's name now being associated with Imperial Brands and its C$123 million investment, it has definitely given it a chance to change that negative sentiment around and make believers of shareholders once again.In the near term the vapes business will provide the immediate impact on the performance of the company, although that won't start to happen meaningfully in the first quarter of calendar year 2020. The earnings report for that time period will give a glimpse into what expectations for investors will be.At the same time, expectations need to be tempered because it's uncertain at what pace products will be distributed and how long it'll take to fully serve the Canadian market. It could take longer than some think at this time, which is probably part of the reason the temporary boost in the share price of the company didn't hold.Auxly will definitely need to use some of that capital to land more streaming deals as well, as it needs to show some ability to generate a predictable stream of income, which is one of the attractions a streaming company of any type has for investors.For now, Auxly Cannabis remains a high risk stock in my opinion, even with the cash infusion from Imperial. It'll take time for it to turn itself around, but if it can, and the vape business takes off relatively soon after Canada allows derivatives to be sold, it could start to change the narrative to a more positive one for the company.I think, with the company as it is today, most investors are going to maintain a wait-and-see attitude until after the first earnings report of 2020, to get more visibility on the viability of the company and how long it'll take for it to generate some sustainable revenue.The good news is the capital should allow it to enter into more deals that may provide it with more revenue in the short term. If that happens, the share price could take off before 2020.See price targets and analyst ratings on TipRanks
- GlobeNewswire
Auxly Welcomes $123 Million Investment and R&D Partnership with Imperial Brands
Auxly Cannabis Group Inc. (XLY.V) (CBWTF) (“Auxly”), an international cannabis company, today announced that Imperial Brands PLC (“Imperial Brands”) will invest approximately $123 million in Auxly by way of a convertible debenture and grant Auxly global licences to Imperial Brands’ vaping technology and access to its vapor innovation business, Nerudia (the “Transaction”). “This investment from Imperial Brands will enhance Auxly’s ability to continue to deliver on our business plans and accelerate our growth initiatives to expand our portfolio of branded derivative products,” said Hugo Alves, President of Auxly.
- GlobeNewswire
Auxly Announces Opening of Kolab Project’s Flagship Retail Store in Saskatchewan
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced the official opening of LAB001, the flagship retail location of its wholly- owned subsidiary, Kolab Project Inc. (“Kolab”). LAB001, located at #7, 3427 - 50 Avenue in Lloydminster, Saskatchewan, is open and operational as of July 11, 2019. In conjunction with the opening of the retail location, Kolab is now able to commence province-wide e-commerce sales in Saskatchewan.
Oilprice.comHow Tech Is About To Solve The Cannabis Industry’s Biggest Problem
The cannabis revolution is just getting started, but the real money is being made behind the scenes, right under the noses of some of the industry’s most savvy investors
- Motley Fool
3 Marijuana Penny Stocks That Are Actually Major Players
You could probably buy a share of each of these cannabis penny stocks with the loose change in your couch cushions.
- GlobeNewswire
Auxly Announces Appointment of Andrew MacMillan as VP, Commercial Business Development
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") is pleased to announce the appointment of Andrew MacMillan as Vice President, Commercial Business Development. Mr. MacMillan most recently served as the Chief Executive Officer of the PEI Liquor Control Commission, which is responsible for the regulation and sale of cannabis through its related corporation, the Cannabis Management Corporation. In his role as CEO, Mr. MacMillan oversaw the regulation of cannabis and the establishment of the PEI Cannabis retail operations, which are regarded as among the most successful in the country.
- GlobeNewswire
Auxly Announces Strategic Agreement with Lonza for Liquid Filled Capsules and Fill and Seal Technology
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly") is pleased to announce that Auxly’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”) has entered into a definitive agreement with Capsugel Inc., a subsidiary of Lonza Group Ltd. (“Capsugel”), to provide Dosecann with a complete line of equipment for capsule filling and sealing, including a state-of-the-art LEMS® machine, Lonza’s proprietary liquid-filled Capsugel® Licaps® capsules, and rights to its capsule filling and sealing LEMS® technology. In addition, Dosecann and Lonza will work collaboratively on new product formulation for cannabis capsule products. Lonza’s technology is currently used for several functional improvements in health and nutritional applications, including bioavailability enhancement, taste and odor masking, combination products, and controlled and delayed release.
- PR Newswire
OTC Markets Group Launches OTCQX Cannabis Index
NEW YORK , June 4, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the launch of the OTCQX® Cannabis Index ...
- Motley Fool
Auxly Cannabis Group's First-Quarter Loss Widens as It Focuses on Marijuana Derivatives
Auxly recorded its first marijuana sales in Q1, but revenue isn't expected to really pick up until October.
- GlobeNewswire
Auxly Reports Q1 2019 Financial Results and Highlights Key Milestones
VANCOUVER, British Columbia, May 27, 2019 -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) ("Auxly" or the "Company") today released its financial results for the.
- Oilprice.com
The Marijuana Industry’s Dirty Little Secret
Cannabis cultivation requires enormous amounts of energy, and water, and the companies that employ smart solutions are now pulling ahead in the highly competitive cannabis boom
- Motley Fool
3 Dawdling Cannabis Stocks: Can They Catch Up?
These three marijuana stocks have underperformed in 2019, and investors want to know if they'll return to their former glory.
- ACCESSWIRE
Cannabis Industry Could Be Recession Proof
HENDERSON, NV / ACCESSWIRE / April 9, 2019 / With some analysts calling for a potential recession, they are predicting the cannabis industry will be one of the top industries capable of delivering a healthy ...
- GlobeNewswire
Auxly Announces Receipt of Cultivation and Processing Licences for Robinsons Cannabis Facility
Auxly Cannabis Group Inc. (TSX.V - XLY) ("Auxly" or the "Company") today announced that its wholly-owned subsidiary, Robinsons Cannabis Inc. (“Robinsons”), has been granted standard cultivation and processing licences by Health Canada pursuant to the Cannabis Act and Cannabis Regulations. The licences give Robinsons the ability to begin cultivation at its fully constructed 27,700 square-foot facility in Kentville, Nova Scotia, which was purpose-built to produce high-quality cannabis. Led by experienced head grower Andrew Robinson, Robinsons is uniquely positioned to capture the attention of luxury cannabis consumers, with operations built on a devotion to uncompromising quality and a premium cannabis experience.
- Motley Fool
Better Marijuana Stock: CannTrust Holdings vs. Auxly Cannabis
Which stock wins in a battle between two small Canadian marijuana companies?
- Motley Fool
Auxly Cannabis's Full-Year Loss Widens as It Waits for Partnered Production to Come Online
With its ducks now in a row, Auxly readies itself to sell raw cannabis and derivative products in 2019.
